95 related articles for article (PubMed ID: 20651084)
1. Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling.
Luis TC; Naber BA; Fibbe WE; van Dongen JJ; Staal FJ
Blood; 2010 Jul; 116(3):496-7. PubMed ID: 20651084
[No Abstract] [Full Text] [Related]
2. Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation.
Luis TC; Weerkamp F; Naber BA; Baert MR; de Haas EF; Nikolic T; Heuvelmans S; De Krijger RR; van Dongen JJ; Staal FJ
Blood; 2009 Jan; 113(3):546-54. PubMed ID: 18832654
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation.
Nemeth MJ; Topol L; Anderson SM; Yang Y; Bodine DM
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15436-41. PubMed ID: 17881570
[TBL] [Abstract][Full Text] [Related]
4. Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals.
Malhotra S; Baba Y; Garrett KP; Staal FJ; Gerstein R; Kincade PW
J Immunol; 2008 Sep; 181(6):3955-64. PubMed ID: 18768850
[TBL] [Abstract][Full Text] [Related]
5. WNT proteins: environmental factors regulating HSC fate in the niche.
Luis TC; Staal FJ
Ann N Y Acad Sci; 2009 Sep; 1176():70-6. PubMed ID: 19796234
[TBL] [Abstract][Full Text] [Related]
6. Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells.
Malhotra S; Kincade PW
Exp Hematol; 2009 Jan; 37(1):19-30. PubMed ID: 18951693
[TBL] [Abstract][Full Text] [Related]
7. Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis.
Famili F; Naber BA; Vloemans S; de Haas EF; Tiemessen MM; Staal FJ
Cell Death Dis; 2015 Nov; 6(11):e1981. PubMed ID: 26583322
[TBL] [Abstract][Full Text] [Related]
8. Integration of Shh and Wnt Signaling Pathways Regulating Hematopoiesis.
Zhou Z; Wan L; Wang C; Zhou K
DNA Cell Biol; 2015 Dec; 34(12):710-6. PubMed ID: 26378473
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.
Hay DC; Fletcher J; Payne C; Terrace JD; Gallagher RC; Snoeys J; Black JR; Wojtacha D; Samuel K; Hannoun Z; Pryde A; Filippi C; Currie IS; Forbes SJ; Ross JA; Newsome PN; Iredale JP
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12301-6. PubMed ID: 18719101
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
Oloumi A; Syam S; Dedhar S
Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
[TBL] [Abstract][Full Text] [Related]
11. Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells.
Qiu W; Chen L; Kassem M
Biochem Biophys Res Commun; 2011 Sep; 413(1):98-104. PubMed ID: 21875572
[TBL] [Abstract][Full Text] [Related]
12. Liposomal packaging generates Wnt protein with in vivo biological activity.
Morrell NT; Leucht P; Zhao L; Kim JB; ten Berge D; Ponnusamy K; Carre AL; Dudek H; Zachlederova M; McElhaney M; Brunton S; Gunzner J; Callow M; Polakis P; Costa M; Zhang XM; Helms JA; Nusse R
PLoS One; 2008 Aug; 3(8):e2930. PubMed ID: 18698373
[TBL] [Abstract][Full Text] [Related]
13. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.
Kirstetter P; Anderson K; Porse BT; Jacobsen SE; Nerlov C
Nat Immunol; 2006 Oct; 7(10):1048-56. PubMed ID: 16951689
[TBL] [Abstract][Full Text] [Related]
14. Wnt3a/beta-catenin signaling controls posterior body development by coordinating mesoderm formation and segmentation.
Dunty WC; Biris KK; Chalamalasetty RB; Taketo MM; Lewandoski M; Yamaguchi TP
Development; 2008 Jan; 135(1):85-94. PubMed ID: 18045842
[TBL] [Abstract][Full Text] [Related]
15. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation.
Tu X; Joeng KS; Nakayama KI; Nakayama K; Rajagopal J; Carroll TJ; McMahon AP; Long F
Dev Cell; 2007 Jan; 12(1):113-27. PubMed ID: 17199045
[TBL] [Abstract][Full Text] [Related]
16. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway.
Lengerke C; Schmitt S; Bowman TV; Jang IH; Maouche-Chretien L; McKinney-Freeman S; Davidson AJ; Hammerschmidt M; Rentzsch F; Green JB; Zon LI; Daley GQ
Cell Stem Cell; 2008 Jan; 2(1):72-82. PubMed ID: 18371423
[TBL] [Abstract][Full Text] [Related]
17. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways.
Samarzija I; Sini P; Schlange T; Macdonald G; Hynes NE
Biochem Biophys Res Commun; 2009 Aug; 386(3):449-54. PubMed ID: 19523451
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation.
Baksh D; Boland GM; Tuan RS
J Cell Biochem; 2007 Aug; 101(5):1109-24. PubMed ID: 17546602
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells.
Tamura M; Sato MM; Nashimoto M
Int J Biochem Cell Biol; 2011 May; 43(5):760-7. PubMed ID: 21296678
[TBL] [Abstract][Full Text] [Related]
20. WNT and BMP signaling are both required for hematopoietic cell development from human ES cells.
Wang Y; Nakayama N
Stem Cell Res; 2009; 3(2-3):113-25. PubMed ID: 19595658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
